Jean-Charles Soria, Amgen’s senior vice president of Oncology within Global Development, shared an article on X:
“Cancer cachexia equals to an underdiagnosed, lethal syndrome.
- Affects up to 80% in pancreatic CA, 40% in lung.
- It’s not just weight loss—think systemic inflammation, altered metabolism, fat/muscle wasting.
- GDF-15, IL-6, activin A are key molecular drivers.
- A major unmet need in cancer patients.”
Title: Cancer-Associated Cachexia: Bridging Clinical Findings with Mechanistic Insights in Human Studies
Authors: Kexin Koh, Rachel Scott, Elizabeth M. Cespedes Feliciano, Tobias Janowitz, Marcus D. Goncalves, Eileen P. White, Barry J.A. Laird, Kerstin Haase, and Mariam Jamal-Hanjani
Read The Full Article at Cancer Discovery.
More posts featuring Jean-Charles Soria.